Administration of recombinant renalase attenuated the development of hypertension, cardiomyocytes hypertrophy and cardiac interstitial fibrosis and prevented cardiac remodelling through inhibition of profibrotic genes expression and phosphorylation of ERK‐1/2 36. Here, RNLS is linked to hypertensive disorder.